Literature DB >> 16252068

DBH*444G/A polymorphism of the dopamine-beta-hydroxylase gene is associated with alcoholism but not with severe alcohol withdrawal symptoms.

M D Köhnke1, W Kolb, A M Köhnke, U Lutz, S Schick, A Batra.   

Abstract

As the enzyme dopamine-beta-hydroxylase (DbetaH) converts dopamine to norepinephrine and both transmitters seem to be involved in the pathology of alcoholism and severe alcohol withdrawal symptoms, the gene encoding DbetaH (DBH) was applied to explore the genetic background of alcoholism and severe withdrawal symptoms. 102 healthy control subjects and 208 alcoholics, including 97 patients with a history of mild withdrawal symptoms, 57 with a history of alcohol withdrawal seizure (AWS) and 82 with a history of delirium tremens (DT) were genotyped for the DBH*444G/A polymorphism revealing a significantly elevated frequency of genotypes carrying the A-allele (p = 0.02; after Bonferroni adjustment for multiple tests) in alcoholics compared to healthy controls. Frequencies of alleles and genotypes of individuals with mild withdrawal symptoms did not differ significantly from those of patients with DT or AWS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16252068     DOI: 10.1007/s00702-005-0365-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  39 in total

1.  Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH).

Authors:  J F Cubells; K Kobayashi; T Nagatsu; K K Kidd; J R Kidd; F Calafell; H R Kranzler; H Ichinose; J Gelernter
Journal:  Am J Med Genet       Date:  1997-07-25

2.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

Authors:  J T Sullivan; K Sykora; J Schneiderman; C A Naranjo; E M Sellers
Journal:  Br J Addict       Date:  1989-11

3.  Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism.

Authors:  U Finckh; H Rommelspacher; S Kuhn; P Dufeu; G Otto; A Heinz; M Dettling; M Giraldo-Velasquez; J Pelz; K J Gräf; H Harms; T Sander; L G Schmidt; A Rolfs
Journal:  Pharmacogenetics       Date:  1997-08

4.  Central nervous system noradrenaline metabolism and alcohol consumption in man.

Authors:  S Borg; H Kvande; D Mossberg; P Valverius; G Sedvall
Journal:  Pharmacol Biochem Behav       Date:  1983       Impact factor: 3.533

5.  DAT1 gene polymorphism in alcoholism: a family-based association study.

Authors:  P Franke; S G Schwab; M Knapp; M Gänsicke; C Delmo; P Zill; M Trixler; D Lichtermann; J Hallmayer; D B Wildenauer; W Maier
Journal:  Biol Psychiatry       Date:  1999-03-01       Impact factor: 13.382

6.  Behavioral disinhibition following basal forebrain excitotoxin lesions: alcohol consumption, defensive aggression, impulsivity and serotonin levels.

Authors:  A K Johansson; A H Bergvall; S Hansen
Journal:  Behav Brain Res       Date:  1999-07       Impact factor: 3.332

7.  Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Correlations with clinical signs.

Authors:  R J Hawley; L F Major; E A Schulman; M Linnoila
Journal:  Arch Gen Psychiatry       Date:  1985-11

8.  Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34.

Authors:  S P Craig; V J Buckle; A Lamouroux; J Mallet; I W Craig
Journal:  Cytogenet Cell Genet       Date:  1988

9.  Neurogenetic adaptive mechanisms in alcoholism.

Authors:  C R Cloninger
Journal:  Science       Date:  1987-04-24       Impact factor: 47.728

10.  Dopamine-beta-hydroxylase activity levels in men at high risk for alcoholism and controls.

Authors:  M A Schuckit; D T O'Connor; J Duby; R Vega; M Moss
Journal:  Biol Psychiatry       Date:  1981-11       Impact factor: 13.382

View more
  7 in total

1.  Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer's disease.

Authors:  Miwa Komatsu; Nobuto Shibata; Tohru Ohnuma; Bolati Kuerban; Katrin Tomson; Aiko Toda; Yuko Tagata; Tomoko Nakada; Hiromi Shimazaki; Heii Arai
Journal:  J Neural Transm (Vienna)       Date:  2013-11-08       Impact factor: 3.575

Review 2.  Drosophila and Caenorhabditis elegans as Discovery Platforms for Genes Involved in Human Alcohol Use Disorder.

Authors:  Mike Grotewiel; Jill C Bettinger
Journal:  Alcohol Clin Exp Res       Date:  2015-07-14       Impact factor: 3.455

3.  An Exploratory Association Study of Alcohol Use Disorder and DNA Methylation.

Authors:  Sarah L Hagerty; L Cinnamon Bidwell; Nicole Harlaar; Kent E Hutchison
Journal:  Alcohol Clin Exp Res       Date:  2016-07-08       Impact factor: 3.455

4.  Regulatory polymorphisms in human DBH affect peripheral gene expression and sympathetic activity.

Authors:  Elizabeth S Barrie; David Weinshenker; Anurag Verma; Sarah A Pendergrass; Leslie A Lange; Marylyn D Ritchie; James G Wilson; Helena Kuivaniemi; Gerard Tromp; David J Carey; Glenn S Gerhard; Murray H Brilliant; Scott J Hebbring; Joseph F Cubells; Julia K Pinsonneault; Greg J Norman; Wolfgang Sadee
Journal:  Circ Res       Date:  2014-10-17       Impact factor: 17.367

Review 5.  Noradrenergic circuits and signaling in substance use disorders.

Authors:  Anthony M Downs; Zoe A McElligott
Journal:  Neuropharmacology       Date:  2022-02-14       Impact factor: 5.273

6.  Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.

Authors:  Rasmon Kalayasiri; Viroj Verachai; Joel Gelernter; Apiwat Mutirangura; Robert T Malison
Journal:  Addiction       Date:  2014-03-17       Impact factor: 6.526

Review 7.  Flying Together: Drosophila as a Tool to Understand the Genetics of Human Alcoholism.

Authors:  Daniel R Lathen; Collin B Merrill; Adrian Rothenfluh
Journal:  Int J Mol Sci       Date:  2020-09-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.